Showing results (311-320 of 582) with videos related to
Sort By:
Pageof 59
The International Journal on Drug Policy|December 17, 2020
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugsMarianne Skov-Skov Bergh, Åse Marit Leere Øiestad, Michael H Baumann, et al.Neurotoxicology|September 19, 2017
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicityNicholas B Miner, Josh S Elmore, Michael H Baumann, et al.Biochemistry|April 28, 1992
Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopyH Baumann, A O Tzianabos, J R Brisson, et al.Brain Research|October 21, 1996
Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluationS F Ali, G D Newport, W Slikker, et al.Psychopharmacology|June 1, 1997
Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in ratsM Shoaib, M H Baumann, R B Rothman, et al.Research in Immunology|June 17, 1998
Nitric oxide downregulates tumour necrosis factor in mRNA in RAW 264.7 cellsB Sinha, A Eigler, K H Baumann, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoproteinS D Yoo, J W Holladay, T K Fincher, et al.ACS Pharmacology & Translational Science|May 20, 2022
Automated Computer Software Assessment of 5-Hydroxytryptamine 2A Receptor-Mediated Head Twitch Responses from Video Recordings of MiceGrant C Glatfelter, Michael R Chojnacki, Shelby A McGriff, et al.Breast Cancer : Basic and Clinical Research|May 11, 2011
Effects of celecoxib and ly117018 combination on human breast cancer cells in vitroKlaus H Baumann, Elmar Klusmeier, Isabel Eggemann, et al.Annals of the New York Academy of Sciences|November 21, 2000
Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaineM H Baumann, J P Pablo, S F Ali, et al.Pageof 59